ACM
CYTK icon

Asymmetry Capital Management’s Cytokinetics CYTK Stock Holding History

Asymmetry Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		$10.3M Sell
225,032
-21,304
-9% -$822K 5.45% 8
2021
Q3 		$8.8M Buy
+246,336
New +$7.25M 5.29% 8
2020
Q4 		– Sell
-340,253
Closed -$7.37M – 36
2020
Q3 		$7.37M Buy
340,253
+134,167
+65% +$3.14M 4.73% 6
2020
Q2 		$4.86M Buy
206,086
+1,835
+0.9% +$34.4K 3.72% 10
2020
Q1 		$2.41M Buy
204,251
+119,079
+140% +$1.52M 2.63% 15
2019
Q4 		$904K Buy
+85,172
New +$875K 1.62% 29

Other funds holding CYTK

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $950M AUM 57.92% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return